Proskauer advised Atlas Venture on the deal.Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, announced the closing of its thirteenth fund….
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
